Le, D. T., Crocenzi, T. S., Urum, J. N., Lutz, E. R., Laheru, D. A., Sugar, E. A., . . . Jaffee, E. M. (2015). Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR). J Immunother Cancer.
Chicago-tyylinen lähdeviittausLe, Dung T., et al. "Randomized Phase II Study of the Safety, Efficacy and Immune Response of GVAX Pancreas (with Cyclophosphamide) and CRS-207 With or Without Nivolumab in Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma (STELLAR)." J Immunother Cancer 2015.
MLA-viiteLe, Dung T., et al. "Randomized Phase II Study of the Safety, Efficacy and Immune Response of GVAX Pancreas (with Cyclophosphamide) and CRS-207 With or Without Nivolumab in Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma (STELLAR)." J Immunother Cancer 2015.